(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 407.46 | 434.83 | 428.70 | -6.3% | -5.0% |
Total Expenses | 451.17 | 433.30 | 410.60 | 4.1% | 9.9% |
Profit Before Tax | -93.51 | 1.52 | 8.43 | -6252.0% | -1209.3% |
Tax | -11.72 | 7.14 | 4.95 | -264.1% | -336.8% |
Profit After Tax | -81.79 | -7.48 | 3.48 | 993.4% | -2450.3% |
Earnings Per Share | -4.60 | -0.20 | 0.60 | 2200.0% | -866.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Camlin Fine Sciences Ltd is a company known for its involvement in the production of specialty chemicals and food additives. The company primarily operates in the chemical industry, focusing on the development and supply of antioxidants and aroma chemicals. Camlin Fine Sciences is committed to providing high-quality products that enhance the shelf life and stability of consumer goods. As of the latest update, there are no recent major developments available regarding the company's strategic initiatives or market expansions.
During the fourth quarter of the fiscal year 2025 (Q4FY25), Camlin Fine Sciences Ltd reported a total income of ₹407.46 crores. This represents a decrease of 6.3% from the previous quarter (Q3FY25), where the total income was ₹434.83 crores. When compared to the same quarter in the previous fiscal year (Q4FY24), there is a decline of 5.0% from an income of ₹428.70 crores. The decline in total income over both the quarter-over-quarter (QoQ) and year-over-year (YoY) periods indicates changes in revenue generation during this period.
In Q4FY25, Camlin Fine Sciences Ltd experienced a significant drop in profitability, with a reported loss before tax of ₹93.51 crores. This marks a stark contrast to the previous quarter's profit before tax of ₹1.52 crores and the profit of ₹8.43 crores recorded in Q4FY24. The profit after tax for Q4FY25 was also negative, standing at a loss of ₹81.79 crores, compared to a loss of ₹7.48 crores in Q3FY25 and a profit of ₹3.48 crores in Q4FY24. These figures reflect a QoQ increase in loss by 993.4% and a YoY decrease in profit by 2450.3%. The earnings per share (EPS) for Q4FY25 were negative at ₹-4.60, compared to ₹-0.20 in Q3FY25 and ₹0.60 in Q4FY24, indicating a substantial deterioration in shareholder returns.
For the fourth quarter of FY25, Camlin Fine Sciences Ltd's total expenses were reported at ₹451.17 crores, which is a 4.1% increase from the previous quarter's expenses of ₹433.30 crores. Compared to the same quarter in the previous fiscal year, where expenses were ₹410.60 crores, there is a 9.9% increase. These rising expenses, alongside declining income, have impacted the company's operating performance during this period. The tax expense for the quarter was negative, amounting to ₹-11.72 crores, compared to ₹7.14 crores in Q3FY25 and ₹4.95 crores in Q4FY24, which reflects a shift in tax liabilities or credits impacting the company's financials.